Scientists pinpoint a nerve cluster in the brain as key player in regulating blood pressure.
A recent study led by Dr. John Collister found that the median preoptic nucleus (MnPO), a cluster of nerves in the hypothalamus, helps direct the body’s blood pressure. Deciphering which parts of the brain regulate the body’s blood pressure could help scientists pin down more effective, lasting treatments for this widespread issue.
Porcine reproductive and respiratory syndrome (PRRS) is a viral disease that impacts the health of pigs and costs the global swine industry a staggering $664 million per year. Controlling PRRS has proven to be a major challenge in part because of the diversity of genetic variants of the virus that are in circulation. In a recent USDA-funded study led by CVM’s Dr. Kimberly VanderWaal and Dr.
Antibiotic use, overuse, and misuse are primary drivers of antimicrobial resistance, which the World Health Organization has identified as one of the greatest global public health threats. Microbes such as bacteria, can adapt over time developing resistance to medicines and rendering treatment ineffective, so that even common infections and minor injuries can become deadly. Use of antibiotics in both human and veterinary medicine contributes to the problem—and both, as the authors of a recent publication argue, are important parts of the solution.
In a recent study, CVM researchers including Dr. Sagar Goyal, Dr. Sunil Mor, and Dr. Vikash Singh examined a strain of Chromobacterium violeceum, a rare but fast-spreading disease that is fatal in elephants that has the potential to be fatal in humans as well. Currently, India is home to over half of the global elephant population. But human development and rapid climate change have compromised large areas of their natural habitats, causing elephant populations to decline and increasing their exposure to a host of risks, including pathogens like C. violaceum.
CVM researchers led by Dr. Pamela Skinner recently received a $480,000 grant from the Foundation for AIDS Research (amfAR) to develop a treatment for durable remission of HIV, which remains a leading cause of death and a threat to millions in some regions of the world.